Skip to content

Effect of Munditika Yog and Apamarga Taila Nasya in the Management of Ardhavbhedak w.s.r. to Migraine

A clinical study to evaluate the respective and cumulative efficacy of Munditika Yog and Apamarga Taila Nasya in the management of Ardhavbhedak W.S.R. to Migraine - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069737
Enrollment
60
Registered
2024-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R908- Other abnormal findings on diagnostic imaging of central nervous system

Interventions

None listed

Sponsors

Madan Mohan Malviya Govt Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients having a history of migraine as defined by Ayurveda classics and International Headache Society, at least one year prior to enrollment and chronicity not exceeding more than five years. ii) Patients willing for trial with consent. iii) Age between 18 to 60 years. iv) Either sex of different socio-economic groups.

Exclusion criteria

Exclusion criteria: i) Age below 18 or more than 60 years. ii) Patients of Ardhavbhedak who are taking other preventive treatment. iii) Patients who are suffering from other chronic diseases. iv) Patients who are suffering from secondary headache of meningitis, brain tumor, encephalitis or having referred pain on one half of the head due to disorders of eye, ear, nose, throat, etc. v) Patients with previous completion or withdrawn from the study. vi) Evidence of significantly active psychiatric disease including manic depressive illness, schizophrenia, generalized anxiety disorder, OCD, and personality disorder. vii) Women who are pregnant or nursing. viii) Excessive alcoholic and with history of drug dependence or drug abuse. ix) Hypersensitive to any of the trial drugs or their ingredients.

Design outcomes

Primary

MeasureTime frame
Aradhashirovedna (unilateral headache), Prakash asahishnuta (Photophobia), Dhwani asahishnuta (Phonophobia), Bhram (Vertigo), Nausea, Vomiting, Severity, freuency and duration of headache wil be analysed g)Tinnitus Timepoint: On 45 day after registration of patients

Secondary

MeasureTime frame
Reduction in signs & symptoms with improved quality & vitality of life.Timepoint: At 15, 30 & 45 day after registration of patient.

Countries

India

Contacts

Public ContactDr Teena Verma

Madan Mohan Malviya Government Ayurved College

drindusharma4@gmail.com7976972310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026